GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: AFMD
Buy $15

Affimed Therapeutics B.V. (NASDAQ: AFMD) rated to Buy with price target $15 by Laidlaw

Thursday,  Dec 10, 2015  9:25 AM ET by Kristen Bailey

Laidlaw rated Affimed Therapeutics
B.V. (NASDAQ: AFMD) to Buy with price target $15.



Laidlaw



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy